IDEX Corporation — Third Quarter 2026 Earnings Summary

IDEX Corporation reported record third-quarter sales of $952 million, representing an 8% increase on both a reported and organic basis compared to the prior year. The company achieved a reported diluted earnings per share of $1.95 and a record adjusted diluted earnings per share of $2.33, both reflecting a 15% year-over-year growth. Orders reached a new high of $991 million, up 13% from the previous period, driven by strong demand in the Health & Science Technologies segment and positive pricing across all business units. In response to this performance, IDEX raised its full-year organic sales growth guidance to a range of 6.5% to 6.8% and increased its adjusted diluted EPS outlook to between $8.91 and $8.96.